Aviva’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $104M | Buy |
1,798,345
+31,186
| +2% | +$1.79M | 0.15% | 122 |
|
|
2026
Q1 | $107M | Buy |
1,767,159
+51,415
| +3% | +$3M | 0.18% | 108 |
|
|
2025
Q4 | $92.5M | Buy |
1,715,744
+91,710
| +6% | +$4.41M | 0.16% | 130 |
|
|
2025
Q3 | $73.2M | Buy |
1,624,034
+91,882
| +6% | +$4.29M | 0.13% | 150 |
|
|
2025
Q2 | $70.9M | Buy |
1,532,152
+115,044
| +8% | +$5.65M | 0.15% | 144 |
|
|
2025
Q1 | $86.4M | Buy |
1,417,108
+195,772
| +16% | +$11.4M | 0.21% | 108 |
|
|
2024
Q4 | $69.1M | Buy |
1,221,336
+248,348
| +26% | +$13.9M | 0.18% | 120 |
|
|
2024
Q3 | $50.3M | Buy |
972,988
+22,802
| +2% | +$1.07M | 0.13% | 187 |
|
|
2024
Q2 | $39.5M | Buy |
950,186
+159,504
| +20% | +$7.14M | 0.11% | 221 |
|
|
2024
Q1 | $42.9M | Sell |
790,682
-19,021
| -2% | -$969K | 0.14% | 153 |
|
|
2023
Q4 | $41.5M | Sell |
809,703
-40,702
| -5% | -$2.14M | 0.15% | 142 |
|
|
2023
Q3 | $49.4M | Sell |
850,405
-108,781
| -11% | -$6.67M | 0.21% | 90 |
|
|
2023
Q2 | $61.3M | Buy |
959,186
+195,646
| +26% | +$13.1M | 0.25% | 74 |
|
|
2023
Q1 | $52.9M | Sell |
763,540
-83,309
| -10% | -$5.88M | 0.24% | 80 |
|
|
2022
Q4 | $60.9M | Buy |
846,849
+67,639
| +9% | +$5.1M | 0.3% | 60 |
|
|
2022
Q3 | $55.4M | Buy |
779,210
+37,077
| +5% | +$2.69M | 0.32% | 50 |
|
|
2022
Q2 | $57.1M | Buy |
742,133
+62,366
| +9% | +$4.75M | 0.3% | 57 |
|
|
2022
Q1 | $49.6M | Sell |
679,767
-39,939
| -6% | -$2.68M | 0.25% | 76 |
|
|
2021
Q4 | $44.9M | Sell |
719,706
-31,858
| -4% | -$1.87M | 0.19% | 113 |
|
|
2021
Q3 | $44.5M | Sell |
751,564
-68,091
| -8% | -$4.48M | 0.2% | 110 |
|
|
2021
Q2 | $54.8M | Sell |
819,655
-80,904
| -9% | -$5.28M | 0.24% | 90 |
|
|
2021
Q1 | $56.9M | Sell |
900,559
-386,682
| -30% | -$24.1M | 0.28% | 83 |
|
|
2020
Q4 | $79.8M | Buy |
1,287,241
+40,565
| +3% | +$2.49M | 0.42% | 52 |
|
|
2020
Q3 | $75.2M | Sell |
1,246,676
-31,230
| -2% | -$1.88M | 0.44% | 49 |
|
|
2020
Q2 | $75.1M | Buy |
1,277,906
+90,359
| +8% | +$5.4M | 0.47% | 51 |
|
|
2020
Q1 | $66.2M | Buy |
1,187,547
+63,311
| +6% | +$3.87M | 0.48% | 48 |
|
|
2019
Q4 | $72.2M | Buy |
1,124,236
+264,461
| +31% | +$15.1M | 0.44% | 53 |
|
|
2019
Q3 | $43.6M | Buy |
859,775
+124,511
| +17% | +$5.85M | 0.3% | 81 |
|
|
2019
Q2 | $33.3M | Sell |
735,264
-14,871
| -2% | -$693K | 0.23% | 97 |
|
|
2019
Q1 | $35.8M | Sell |
750,135
-1,372
| -0.2% | -$68.3K | 0.24% | 97 |
|
|
2018
Q4 | $39.1M | Sell |
751,507
-190,358
| -20% | -$10.2M | 0.29% | 88 |
|
|
2018
Q3 | $58.5M | Sell |
941,865
-35,266
| -4% | -$2.09M | 0.32% | 80 |
|
|
2018
Q2 | $54.1M | Sell |
977,131
-13,152
| -1% | -$710K | 0.32% | 79 |
|
|
2018
Q1 | $62.6M | Sell |
990,283
-79,257
| -7% | -$5.1M | 0.38% | 67 |
|
|
2017
Q4 | $65.5M | Sell |
1,069,540
-129,429
| -11% | -$8.1M | 0.37% | 60 |
|
|
2017
Q3 | $76.4M | Buy |
1,198,969
+10,040
| +0.8% | +$586K | 0.41% | 55 |
|
|
2017
Q2 | $66.3M | Buy |
1,188,929
+13,622
| +1% | +$741K | 0.37% | 59 |
|
|
2017
Q1 | $63.9M | Sell |
1,175,307
-60,639
| -5% | -$3.33M | 0.37% | 60 |
|
|
2016
Q4 | $72.2M | Buy |
1,235,946
+67,490
| +6% | +$3.69M | 0.43% | 47 |
|
|
2016
Q3 | $63M | Buy |
1,168,456
+28,449
| +2% | +$1.83M | 0.39% | 55 |
|
|
2016
Q2 | $83.9M | Buy |
1,140,007
+141,320
| +14% | +$9.99M | 0.57% | 41 |
|
|
2016
Q1 | $63.8M | Buy |
998,687
+6,789
| +0.7% | +$428K | 0.47% | 47 |
|
|
2015
Q4 | $68.2M | Buy |
991,898
+4,375
| +0.4% | +$289K | 0.52% | 44 |
|
|
2015
Q3 | $58.5M | Sell |
987,523
-52,189
| -5% | -$3.31M | 0.48% | 47 |
|
|
2015
Q2 | $69.2M | Sell |
1,039,712
-149,990
| -13% | -$9.88M | 0.49% | 48 |
|
|
2015
Q1 | $76.7M | Buy |
1,189,702
+178,042
| +18% | +$11.1M | 0.53% | 42 |
|
|
2014
Q4 | $59.7M | Buy |
1,011,660
+880
| +0.1% | +$49.6K | 0.46% | 51 |
|
|
2014
Q3 | $51.7M | Buy |
1,010,780
+152,631
| +18% | +$7.62M | 0.41% | 51 |
|
|
2014
Q2 | $41.6M | Buy |
858,149
+75,467
| +10% | +$3.72M | 0.32% | 73 |
|
|
2014
Q1 | $40.7M | Buy |
782,682
+25,053
| +3% | +$1.33M | 0.33% | 71 |
|
|
2013
Q4 | $40.3M | Sell |
757,629
-2,929
| -0.4% | -$149K | 0.34% | 70 |
|
|
2013
Q3 | $35.2M | Buy |
760,558
+105,598
| +16% | +$4.64M | 0.31% | 75 |
|
|
2013
Q2 | $29.3M | Buy |
+654,960
| New | +$28.4M | 0.3% | 82 |
|
Other funds holding BMY
Aviva's BMY Position: Q2 2026 in Review
Aviva increased its Bristol-Myers Squibb (BMY) stake by 1.8% in Q2 2026, buying an estimated $1.79M and bringing the position to 1,798,345 shares worth $104M. The position accounts for 0.15% of the portfolio, ranked #122.
Aviva first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $107M in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Aviva held 1,798,345 shares of Bristol-Myers Squibb worth $104M as of Q2 2026.
- Aviva bought 31,186 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.79M.
- Bristol-Myers Squibb made up 0.15% of Aviva's portfolio in Q2 2026, its #122 holding.
- Aviva first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Aviva's Bristol-Myers Squibb position peaked at $107M in Q1 2026.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.